Measles-mumps-rubella vaccine at 6 months of age, immunology, and childhood morbidity in a high-income setting: study protocol for a randomized controlled trial

Overview of attention for article published in Trials, December 2020

Altmetric Badge

Mentioned by

news: 1 news outlet

twitter: 10 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 37 Mendeley

Summary News X Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

Epidemiological Features of Infectious Diseases in Children and Adolescents: A Population-Based Observational Study in Shandong Province, China, 2013–2017

Article in Children (March 2024)

Immunogenicity and reactogenicity following MMR vaccination in 5–7-month-old infants: a double-blind placebo-controlled randomized clinical trial in 6540 Danish infants

Article in EClinicalMedicine (January 2024)

Measles, mumps, and rubella vaccine at age 6 months and hospitalisation for infection before age 12 months: randomised controlled trial

Article in The BMJ (June 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.